208 related articles for article (PubMed ID: 15626643)
1. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA.
Pfau JC; Sentissi JJ; Weller G; Putnam EA
Environ Health Perspect; 2005 Jan; 113(1):25-30. PubMed ID: 15626643
[TBL] [Abstract][Full Text] [Related]
2. Case series: rheumatological manifestations attributed to exposure to Libby Asbestiform Amphiboles.
Diegel R; Black B; Pfau JC; McNew T; Noonan C; Flores R
J Toxicol Environ Health A; 2018; 81(15):734-747. PubMed ID: 29927712
[TBL] [Abstract][Full Text] [Related]
3. Mesothelial cell and anti-nuclear autoantibodies associated with pleural abnormalities in an asbestos exposed population of Libby MT.
Marchand LS; St-Hilaire S; Putnam EA; Serve KM; Pfau JC
Toxicol Lett; 2012 Jan; 208(2):168-73. PubMed ID: 22085844
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos.
Salazar KD; Copeland CB; Wood CE; Schmid JE; Luebke RW
J Immunotoxicol; 2013; 10(4):329-33. PubMed ID: 23256773
[TBL] [Abstract][Full Text] [Related]
5. Nested case-control study of autoimmune disease in an asbestos-exposed population.
Noonan CW; Pfau JC; Larson TC; Spence MR
Environ Health Perspect; 2006 Aug; 114(8):1243-7. PubMed ID: 16882533
[TBL] [Abstract][Full Text] [Related]
6. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA.
Peipins LA; Lewin M; Campolucci S; Lybarger JA; Miller A; Middleton D; Weis C; Spence M; Black B; Kapil V
Environ Health Perspect; 2003 Nov; 111(14):1753-9. PubMed ID: 14594627
[TBL] [Abstract][Full Text] [Related]
7. Analysis of autoantibody profiles in two asbestiform fiber exposure cohorts.
Pfau JC; Barbour C; Black B; Serve KM; Fritzler MJ
J Toxicol Environ Health A; 2018; 81(19):1015-1027. PubMed ID: 30230971
[TBL] [Abstract][Full Text] [Related]
8. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study.
Sullivan PA
Environ Health Perspect; 2007 Apr; 115(4):579-85. PubMed ID: 17450227
[TBL] [Abstract][Full Text] [Related]
9. A review of the federal government's health activities in response to asbestos-contaminated ore found in Libby, Montana.
Horton K; Kapil V; Larson T; Muravov O; Melnikova N; Anderson B
Inhal Toxicol; 2006 Nov; 18(12):925-40. PubMed ID: 16920666
[TBL] [Abstract][Full Text] [Related]
10. Exposure to airborne amphibole structures and health risks: Libby, Montana.
Price B
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S97-S109. PubMed ID: 18006127
[TBL] [Abstract][Full Text] [Related]
11. Amphibole asbestos in tree bark--a review of findings for this inhalational exposure source in Libby, Montana.
Ward TJ; Spear TM; Hart JF; Webber JS; Elashheb MI
J Occup Environ Hyg; 2012; 9(6):387-97. PubMed ID: 22577793
[TBL] [Abstract][Full Text] [Related]
12. Mortality from asbestos-associated disease in Libby, Montana 1979-2011.
Naik SL; Lewin M; Young R; Dearwent SM; Lee R
J Expo Sci Environ Epidemiol; 2017 Mar; 27(2):207-213. PubMed ID: 27025411
[TBL] [Abstract][Full Text] [Related]
13. Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases.
Antao VC; Larson TC; Horton DK
Curr Opin Pulm Med; 2012 Mar; 18(2):161-7. PubMed ID: 22139761
[TBL] [Abstract][Full Text] [Related]
14. Select mortality and cancer incidence among residents in various U.S. communities that received asbestos-contaminated vermiculite ore from Libby, Montana.
Horton DK; Bove F; Kapil V
Inhal Toxicol; 2008 Jun; 20(8):767-75. PubMed ID: 18569099
[TBL] [Abstract][Full Text] [Related]
15. A clinical assessment and lung tissue burden from an individual who worked as a Libby vermiculite miner.
Black B; Dodson RF; Bruce JR; Poye LW; Henschke C; Loewen G
Inhal Toxicol; 2017 Aug; 29(9):404-413. PubMed ID: 29039215
[TBL] [Abstract][Full Text] [Related]
16. Use of direct versus indirect preparation data for assessing risk associated with airborne exposures at asbestos-contaminated sites.
Goldade MP; O'Brien WP
J Occup Environ Hyg; 2014; 11(2):67-76. PubMed ID: 24369928
[TBL] [Abstract][Full Text] [Related]
17. Environmental exposure to Libby Asbestos and mesotheliomas.
Whitehouse AC; Black CB; Heppe MS; Ruckdeschel J; Levin SM
Am J Ind Med; 2008 Nov; 51(11):877-80. PubMed ID: 18651576
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune antibodies and asbestos exposure: Evidence from Wittenoom, Western Australia.
Reid A; Franklin P; de Klerk N; Creaney J; Brims F; Musk B; Pfau J
Am J Ind Med; 2018 Jul; 61(7):615-620. PubMed ID: 29797780
[TBL] [Abstract][Full Text] [Related]
19. Exposure to asbestos-containing vermiculite ore and respiratory symptoms among individuals who were children while the mine was active in Libby, Montana.
Vinikoor LC; Larson TC; Bateson TF; Birnbaum L
Environ Health Perspect; 2010 Jul; 118(7):1033-28. PubMed ID: 20332072
[TBL] [Abstract][Full Text] [Related]
20. Exposure matrix development for the Libby cohort.
Noonan CW
Inhal Toxicol; 2006 Nov; 18(12):963-7. PubMed ID: 16920669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
